BlackRock Health Sciences Trust (BME) — Capital Reinvestment Ratio
BlackRock Health Sciences Trust (BME) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($959.34K) in capital expenditures ($5.00). See cash generation quality of BlackRock Health Sciences Trust to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BlackRock Health Sciences Trust Capital Reinvestment Ratio (2023–2023)
This chart tracks BlackRock Health Sciences Trust's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for BlackRock Health Sciences Trust (2023–2023)
Year-by-year Capital Reinvestment Ratio for BlackRock Health Sciences Trust from 2023 to 2023. For live market cap and broader valuation context, see BlackRock Health Sciences Trust market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.00x | $32.02 Million | $3.00 | — |